Cargando…
Clinical effectiveness of liraglutide on weight loss in South Koreans: First real-world retrospective data on Saxenda in Asia
Among Asian countries, South Korea was the first to approve liraglutide as a treatment for obesity. Thus, the clinical effectiveness of liraglutide has not been studied in Asian populations. In this study, we retrospectively analyzed obese patients [body mass index (BMI) >27 kg/m(2)] who were tre...
Autores principales: | Park, Joon Seok, Kwon, Jieun, Choi, Hyung Jin, Lee, Changhyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808520/ https://www.ncbi.nlm.nih.gov/pubmed/33466127 http://dx.doi.org/10.1097/MD.0000000000023780 |
Ejemplares similares
-
Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program
por: Wharton, Sean, et al.
Publicado: (2020) -
A randomized controlled trial protocol of the cardiovascular safety and efficacy of liraglutide in the treatment of type 2 diabetes
por: Liang, Ying, et al.
Publicado: (2021) -
Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes: A systematic review and meta-analysis
por: Li, Mingxing, et al.
Publicado: (2017) -
Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National Health and Nutrition Examination Survey, 2008 to 2011
por: Shim, Young Suk, et al.
Publicado: (2017) -
Effects of different weight loss dietary interventions on body mass index and glucose and lipid metabolism in obese patients
por: Ma, Yahui, et al.
Publicado: (2023)